Boughton Soleil sold 6,236 Hims & Hers Health (NYSE: HIMS) shares at $27.86 per share on 16 September 2026. The transaction involved the company’s Chief Legal Officer.
Kayyem Jon Faiz bought 5,000 Inhibrx Biosciences shares at $100 each. For investors tracking insider ownership, the purchase leaves him with 429,360 shares, while the transaction represents about 1.2% of his resulting holding.Key HighlightsKayyem Jon Faiz’s purchase represented about 1.2% of his resulting Inhibrx …
55,000 Derivative Securities Awarded
Altimmune, Inc. (NASDAQ: ALT) is a biotechnology company. Richardson Linda M, the company’s Chief Commercial Officer, exercised options for 24,000 shares at $0 per share on September 16, 2026. She also forfeited 6,826 shares at $3.24 per share on the same date. That forfeited …
ANAPTYSBIO, INC. (NASDAQ: ANAB) is a biotechnology company. Orwin John A exercised options for 1,300 ANAPTYSBIO shares at $0 on September 15, 2026, leaving him with 17,995 shares.
Interim Report Covers Financial and Business Updates
Mensinger Mike, the company’s Chief Product Officer, sold 2,650 shares in the transaction. The disclosed price was $22 per share.
Calidi Biotherapeutics, Inc. (AMEX: CLDI) is a biotechnology company. It is offering 1,025,640 shares of Common Stock at $1.17 per share, with estimated net proceeds of approximately $1.1 million after offering expenses.
Caris Life Sciences, Inc. (NASDAQ: CAI) is a biotechnology company. Brille Brian J exercised options for 400,000 shares at $2.44 per share on 17 September 2026, alongside a separate sale of 400,000 shares at $30.33 per share.
Celli James was awarded 30,554 shares in PSQ Holdings, Inc. (NYSE: PSQH) establishing a new insider position. The award carried prices ranging from $0 to $3.60 per share.